Naringenin lopoulos V, Payne RJ. Self-adjuvanting multponent cancer vaccine candidatesbining per-glycosylated MU glycopeptides and the Toll-like receptor agonist Pa CysSer. Angew Chem Int Ed Engl Finn Gantt Lepisto Pejawar-Gaddy S, Xue J, Beatty PL. Importance of MU and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas. Immunol Res . Barnd Lan Metzgar Finn OJ. Specif Major Histpatibilityplex -Unrestricted Recognition of Tumor-Associated Mucins by Human Cyto-Toxic T-Cells Natl Acad Sci USA. Ioannides Fisk B, Jerome Irimura T, Wharton Finn OJ. Cytotoxic T-Cells from Ovarian Malignant-Tumors Can Recognize Polymorphic Epithelial Mucin Core Peptides.
Journal of Immunology Tang Katsara M, Apostolopoulos V. Strategies used for MU MK-8669 572924-54-0 immunotherapy: human clinical studies. Expert Rev Vaccines. Mukherjee P, Ginardi Tinder Sterner Gendler SJ. MU -specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo. Clinical Cancer Research s . Acres B, Limacher JM. MU as a target antigen for cancer immunotherapy. Expert Review of Vaccines . Agrawal B, Krantz Reddish Longenecker BM. Rapid induction of primary human C and C T cell responses against cancer-associated MU peptide epitopes. International Immunology. Downloaded from clincancerres.aacrjournals on March Copyright American Association for Cancer Research Author Manuscript Published OnlineFirst on March Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Guan Budzynski W, Koganty Krantz Reddish buy MK-4827 Rogers Liposomal formulations of synthetic MU peptides: Effects of encapsulation versus surface display of peptides on immune responses. Bioconjugate Chem .
Butts C, Maksymiuk A, Goss G, Soulieres D, Marshall E, Cormier Y, Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BL liposome vaccine : phase IIB randomiz multicent open-label trial. J Cancer Res Clin Oncol. Babina M, Kirn F, Hoser D, Ernst D, Rohde W, Zuberbier T, Tamoxifen counteracts the allergic PF-04691502 mTOR inhibitor immune response and improves allergen-induced dermatitis in mice. Clin Exp Allergy. Behjati S, Frank MH. The effects of tamoxifen on immunity. Curr Med Chem. Chen Tritton Kenny N, Absher M, Chiu JF. Tamoxifen induces TGF-beta activity and apoptosis of human MCF breast cancer cells in vitro. J Cell Biochem.
Komi J, Lassila O. Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood. Joffroy Buck Stope P Pfizenmaier K, Knabbe C. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer. Cancer Res. Wang Zhang Jin S, Feng Kang Zhao S, Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis. Exp Gerontol . Downloaded from clincancerres.aacrjournals on March hydrazines Copyright American Association for Cancer Research Author Manuscript Published OnlineFirst on March Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Knutson Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.